Nesyrgy (Amlodipine Besilate, Nebivolol Hydrochloride)

Amlodipine besilate blocks L‑type calcium channels in the smooth muscle of arteries, preventing calcium influx that is necessary for contraction. This results in relaxation of the vascular wall, decreased peripheral resistance, and ultimately lower arterial pressure.

The dose of Nesyrgy is individualized by the prescribing clinician based on the patient’s blood‑pressure readings, overall health status, and response to therapy. The prescriber determines the appropriate strength and dosing schedule for each patient.

Safety data for Nesyrgy during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To request Nesyrgy, submit an enquiry on the product page at gnhindia.com with the desired quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Nesyrgy offers a dual‑action approach, combining a calcium‑channel blocker and a β1‑selective blocker in a single tablet. This can simplify regimens compared with taking separate agents and may provide more consistent blood‑pressure control than monotherapy, while maintaining a safety profile comparable to other combination products.

Store Nesyrgy at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

Nesyrgy is taken orally, usually once daily, with a glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their healthcare provider.

Patients should be alert for signs of severe hypotension such as dizziness, fainting, or rapid heartbeat, as well as bradycardia (unusually slow heart rate) and any swelling of the face, lips, tongue, or throat that could indicate angioedema. Prompt medical attention is required if these symptoms occur.

Nesyrgy is contraindicated in individuals with severe hypotension, cardiogenic shock, second‑ or third‑degree atrioventricular block, uncontrolled heart failure, or known hypersensitivity to either amlodipine, nebivolol, or any excipients in the formulation.